| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |